Facebook
X
LinkedIn
ForwardKey Updates in Bladder Cancer - Enduring
A formalized platform does not exist for clinicians to share clinical trial portfolios among individuals at different institutions. In addition, there is no systematic means for updating providers regarding advances in genitourinary cancers and no established forum for providers with interests in genitourinary cancers to meet. There is a critical lack of knowledge of what clinical trials are available to patients in the Los Angeles area and is rapidly changing treatment options for patients with genitourinary cancers. It is challenging to keep pace with these developments. There are many providers who focus on genitourinary cancers in the Los Angeles area - relatively few know and interact with one another and practice multidisciplinary care optimally.
Target Audience
Medical oncologists, urologists, radiation oncologists with interests in bladder cancer and all other allied health care professionals interested in the subject matter.
Learning Objectives
- Define clinical trial opportunities for patients with bladder cancer in the Southern California region.
- Demonstrate understanding of best clinical practices for systemic therapy for bladder cancer.
- Outline best clinical practices for bladder cancer in radiation and surgery.
Additional Information
| Attachment | Size |
|---|---|
 AB 1195 & AB 241 BIBLIO_Nataliya Mar, MD.pdf | 154.38 KB |
This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.
As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months. Faculty presenters who are in a position to control the content of an educational activity must identify any real or apparent conflict(s) of interest by disclosing to the Department of CME all relevant financial relationships with any ineligible company, which is defined as any entity whose primary business is to produce, market , sell, re-sell or distribute healthcare products used by or on patients. To comply with more intense scrutiny by accreditation agencies, content whose faculty has disclosed any relevant financial relationships with an ineligible company, have been peer reviewed prior to presenting and any potential conflicts relative to the previous disclosure have been resolved.
Presenter: Dr. Nataliya Mar, md has indicated the following relevant financial relationships: Grant/Research Support from Gilead Sciences, Consultant for AVEO Oncology, EMD Serono, and Pfizer, and Speakers Bureau for Eisai, and Merck.
The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.
CME Committee/Reviewer no relevant financial relationships with any ineligible companies: Daneng Li, MD
City of Hope further encourages faculty/ authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 0.5
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 0.5 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Available Credit
- 0.50 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this Key Updates in Bladder Cancer - Enduring for a maximum of 0.50 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 0.50 Attendance
You must be logged in to access this Enduring.
If you are a New User, please create an account first, by clicking on "Register".
Once Logged in:
Click on "Start Activity" to access the educational content for this Enduring activity.
Activity Requirements
In order to earn credit for this activity, participants must:
- Read learning objectives and faculty disclosures
- View Enduring Activity Video
- Complete the Evaluation
Upon satisfactory completion, you will have the option to receive a print out of your certificate.
If you have questions regarding this process, please contact the City of Hope Continuing Medical Education at 626-218-5622 or [email protected]
Estimated timeframe for completion of this activity, including the time to complete the evaluation is 0.5 hours.